These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36293099)

  • 21. Emergence of amantadine-resistant influenza A viruses: epidemiological study.
    Suzuki H; Saito R; Masuda H; Oshitani H; Sato M; Sato I
    J Infect Chemother; 2003 Sep; 9(3):195-200. PubMed ID: 14513385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-Genome Analysis Surveillance of Influenza A Virus Resistance to Polymerase Complex Inhibitors in Eastern Spain from 2016 to 2019.
    Mengual-Chuliá B; Alonso-Cordero A; Cano L; Mosquera MDM; de Molina P; Vendrell R; Reyes-Prieto M; Jané M; Torner N; Martínez AI; Vila J; Díez-Domingo J; Marcos MÁ; López-Labrador FX
    Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33782005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiviral Susceptibilities of Distinct Lineages of Influenza C and D Viruses.
    Takashita E; Murakami S; Matsuzaki Y; Fujisaki S; Morita H; Nagata S; Katayama M; Mizuta K; Nishimura H; Watanabe S; Horimoto T; Hasegawa H
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic characterization of human influenza viruses in the pandemic (2009-2010) and post-pandemic (2010-2011) periods in Japan.
    Dapat IC; Dapat C; Baranovich T; Suzuki Y; Kondo H; Shobugawa Y; Saito R; Suzuki H;
    PLoS One; 2012; 7(6):e36455. PubMed ID: 22761651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
    Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
    Front Immunol; 2019; 10():60. PubMed ID: 30761132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pandemic influenza: preventing the emergence of novel strains and countermeasures to ameliorate its effects.
    Solorzano A; Song H; Hickman D; Pérez DR
    Infect Disord Drug Targets; 2007 Dec; 7(4):304-17. PubMed ID: 18220962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evolution of influenza resistance and treatment.
    Weinstock DM; Zuccotti G
    JAMA; 2009 Mar; 301(10):1066-9. PubMed ID: 19255112
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers.
    García J; Sovero M; Torres AL; Gomez J; Douce R; Barrantes M; Sanchez F; Jimenez M; Comach G; de Rivera I; Agudo R; Kochel T
    Influenza Other Respir Viruses; 2009 Mar; 3(2):69-74. PubMed ID: 19496844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High prevalence of antiviral resistant influenza, and reduced clinical effectiveness of the antivirals against resistant influenza strains].
    Saito R
    Jpn J Antibiot; 2010 Feb; 63(1):81-91. PubMed ID: 20836406
    [No Abstract]   [Full Text] [Related]  

  • 31. Influenza viruses: basic biology and potential drug targets.
    Basler CF
    Infect Disord Drug Targets; 2007 Dec; 7(4):282-93. PubMed ID: 18220960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrahost dynamics of antiviral resistance in influenza A virus reflect complex patterns of segment linkage, reassortment, and natural selection.
    Rogers MB; Song T; Sebra R; Greenbaum BD; Hamelin ME; Fitch A; Twaddle A; Cui L; Holmes EC; Boivin G; Ghedin E
    mBio; 2015 Apr; 6(2):. PubMed ID: 25852163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.
    Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA
    mBio; 2018 Apr; 9(2):. PubMed ID: 29691337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral options and therapeutics against influenza: history, latest developments and future prospects.
    Meseko C; Sanicas M; Asha K; Sulaiman L; Kumar B
    Front Cell Infect Microbiol; 2023; 13():1269344. PubMed ID: 38094741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.
    Handel A; Longini IM; Antia R
    J Theor Biol; 2009 Jan; 256(1):117-25. PubMed ID: 18952105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza virus resistance to antiviral agents: a plea for rational use.
    Poland GA; Jacobson RM; Ovsyannikova IG
    Clin Infect Dis; 2009 May; 48(9):1254-6. PubMed ID: 19323631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
    Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
    Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B.
    Warfield KL; Schaaf KR; DeWald LE; Spurgers KB; Wang W; Stavale E; Mendenhall M; Shilts MH; Stockwell TB; Barnard DL; Ramstedt U; Das SR
    Sci Rep; 2019 May; 9(1):7484. PubMed ID: 31097731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-evolution of immunity and seasonal influenza viruses.
    Han AX; de Jong SPJ; Russell CA
    Nat Rev Microbiol; 2023 Dec; 21(12):805-817. PubMed ID: 37532870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance.
    Furuse Y; Suzuki A; Oshitani H
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4457-63. PubMed ID: 19651904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.